Surrogate viruses for testing virucidal efficacy of chemical disinfectants

Journal of Hospital Infection

Volumn 56, Issue SUPPL. 2, 2004, Pages 49-54

  Steinmann, J ^a  

^a Mikrolab GmbH   (Germany)

Author keywords

HBV; HCV; Norovirus; Surrogate viruses; Virucidal efficacy

Indexed keywords

DISINFECTANT AGENT;

ARTICLE; CALICIVIRUS; CELL CULTURE; DISEASE MARKER; DISINFECTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFECTION RISK; INTERMETHOD COMPARISON; NONHUMAN; PHYSICAL CHEMISTRY; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; VIRUS GENOME; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS MORPHOLOGY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS SURVIVAL; VIRUS TRANSMISSION;

EID: 1942484315     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2003.12.030     Document Type: Article

References (24)

1. Guidelines of Bundesgesundheitsamt (BGA; German Federal Health Office) and Deutsche Vereinigung zur Bekämpfung der Viruskrankheiten e.V. (DVV; German Society for the Control of Virus Diseases) for testing the effectiveness of chemical disinfectants against viruses. Zbl Hyg 1990;189:554-562.
2. prEN 14476. Chemical disinfectants and antiseptics-virucidal quantitative suspension test for chemical disinfectants and antiseptics used in human medicine-Test method and requirements (phase 2, step 1); 2002.
3. Drosten C. Gunther S. Preiser W. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome N Engl J Med 348 2003 1967-1976
4. Payan C. Cottin J. Lemarie C. Ramont C. Inactivation of hepatitis B virus in plasma by hospital in-use chemical disinfectant assessed by a modified HepG2 cell culture J Hosp Infect 47 2001 282-287
5. Jursch C.A. Gerlich W.H. Glebe D. Schaefer O.M. Thraenhart O. Molecular approaches to validate disinfectants against human hepatitis B virus Med Microbiol Immunol 190 2002 189-197
6. Kock J. Nassal M. MacNelly S. Baumert T.F. Blum H.E. von Weizsacker F. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus J Virol 75 2001 5084-5089
7. Murray S.M. Freiman J.S. Vickery K. Lim D. Cossart Y.E. Whiteley R.K. Duck hepatitis B virus: a model to assess efficacy of disinfectants against hepadnavirus infectivity Epidemiol Infect 106 1991 435-443
8. Tsiquaye K.N. Barnard J. Chemical disinfection of duck hepatitis B virus: a model for inactivation of hepatitis B virus J Antimicrob Chemother 32 1993 313-323
9. Vickery K. Deva A.K. Zou J. Kumaradeva P. Bissett L. Cossart Y.E. Inactivation of duck hepatitis B virus by a hydrogen peroxide gas plasma sterilization system: laboratory and 'in use' testing J Hosp Infect 41 1999 317-322
10. Wang C.-Y.J. Giambrone J.J. Smith B.F. Development of viral disinfectant assays for duck hepatitis B virus using cell culture/PCR J Virol Methods 106 2002 39-50
11. Wang C.-Y.J. Giambrone J.J. Smith B.F. Comparison of cell culture systems for duck hepatitis B virus using SyBr green quantitative PCR J Virol Methods 106 2002 175-184
12. Chaufour X. Deav A.K. Vickery K. et al. Evaluation of disinfection and sterilization of reusable angioscopes with the duck hepatitis B model J Vasc Surg 30 1999 277-282
13. Ohba K. Mizokami M. Lau J.Y. Orito E. Ikeo K. Gojobori T. Evolutionary relationship of hepatitis C, pest- flavi-, plant viruses and newly discovered GB hepatitis agents FEBS Lett 378 1996 232-234
14. Valli M.B. Carloni G. Manzin A. Nasorri F. Ponzetto A. Clementi M. Hepatitis C virus infection of a Vero cell clone displaying efficient virus-cell binding Res Virol 148 1997 181-186
15. Agoloni G. Russo A. Clementi M. Effect of phenolic and chlorine disinfectants on hepatitis C binding and infectivity Am J Infect Control 27 1999 236-239
16. Charrel R.N. de Chesse R. Decaudin A. De Micco P. de Lamballerie X. Evaluation of disinfectant efficacy against hepatitis C virus using a RT-PCR-based method J Hosp Infect 49 2001 129-134
17. Lopman B.A. Brown D.W. Koopmans M. Human calicivirus in Europe J Clin Virol 24 2002 137-160
18. Chadwick P.R.G. Beards D. Brown E.O. et al. Management of hospital outbreaks of gastro-enteritis due to small roundstructured viruses J Hosp Infect 46 2000 1-10
19. Jiang X. Wang M. Wang K. Estes M.K. Sequence and genomic organization of Norwalk virus Virology 195 1993 51-61
20. Slomka M.J. Appleton H. Feline calicivirus as a model system for heat inactivation studies of small round structured viruses in shellfish Epidemiol Infect 121 1998 401-407
21. Bidawed S. Malik N. Adegunrin O. Sattar S.S. Farber J.M. A feline kidney cell line-based plaque assay for feline calicivirus, a surrogate for Norwalk virus J Virol Methods 107 2003 163-167
22. Scott F.W. Virucidal disinfectants and feline viruses Am J Vet Res 41 1980 410-414
23. Doultree J.C. Druce J.D. Birch C.J. Bowden D.S. Marshall J.A. Inactivation of feline calicivirus, a Norwalk virus surrogate J Hosp Infect 41 1999 51-57
24. ASTM International, 2002 Standard test method for determinating the virus-eliminating effectiveness of liquid hygienic handwash and handrub agents using the fingerpads of adult volunteers. Designation: E-1838-02 2002 ASTM West Conshohocken, PA